Kyntra Bio (KYNB) Change in Acquisitions & Divestments (2014 - 2026)

Kyntra Bio has reported Change in Acquisitions & Divestments for 12 years, with the latest figure at $14.1 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $14.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.8 million (down 78.63% YoY) and the FY2024 annual result came in at $133.8 million, down 66.59% from the prior year.
• Change in Acquisitions & Divestments grew to $14.1 million in Q1 2026 per KYNB's latest filing, from $1.7 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $107.6 million in Q3 2023 and troughed at $1.7 million in Q4 2024.
• A 4-year average of $69.4 million and a median of $74.2 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments jumped 181097.62% in 2022, then slumped 98.34% in 2024.
• Over 4 years, Change in Acquisitions & Divestments stood at $68.1 million in 2022, then jumped by 46.9% to $100.1 million in 2023, then plunged by 98.34% to $1.7 million in 2024, then soared by 752.41% to $14.1 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $14.1 million, $1.7 million, and $72.2 million for Q1 2026, Q4 2024, and Q2 2024 respectively.